Simpler, Less Expensive Test for Ulcer Bug

Publication
Article
OncologyONCOLOGY Vol 12 No 1
Volume 12
Issue 1

Researchers from the University of Wurzburg in Germany have determined that a simple antibody test may be as effective in detecting Helicobacter pylori infection as the more invasive procedures that are currently used. They reported their findings

Researchers from the University of Wurzburg in Germany have determined that a simple antibody test may be as effective in detecting Helicobacter pylori infection as the more invasive procedures that are currently used. They reported their findings in the December 1997 issue of the Journal of Clinical Microbiology.

In the study, the researchers compared the sensitivity of a test for Hpylori-specific immunoglobulin G (IgG) antibodies with the standard tests in clinical practice. The antibody test had a 98% sensitivity, correctly diagnosing 58 of the 59 patients diagnosed by standard methods.

“The current gold standard tests in clinical practice, endoscopy for histology and the rapid urease test, are limited by their relatively high costs and the need for invasive procedures,” say the researchers. “Determination of antibodies against H pylori presents a relatively simple diagnostic method, with kits that can be used to perform this method now...readily available from commercial sources.”

Helicobacter pylori is a bacterium that lives in the harsh acidic environment of the stomach. The cause of most duodenal ulcers and an estimated 70% to 80% of gastric ulcers, H pylori is considered to be a risk factor for stomach cancer. 

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Testing a patient’s genetics may influence decisions such as using longer courses of radiotherapy, says Rachit Kumar, MD.
Spatial transcriptomics and multiplex immunohistochemistry from samples may elucidate outcomes for patients who undergo surgical care for cancer.
Future work may focus on optimizing symptom management associated with percutaneous transesophageal gastrostomy placement in malignant bowel obstructions.
Post-operative length of stay ranged from 4 to 9 days for patients who underwent percutaneous transesophageal gastrostomy for malignant bowel obstructions.
Treatment with KRAS inhibitors may help mitigate a common driver of genetic alteration across a majority of pancreatic cancers.
Various methods of communication ensure that members from radiation oncology, pathology, and other departments are on the same page regarding treatment.
Updated results from the BREAKWATER study seemed to be most impactful to the CRC space, according to Michael J. Pishvaian, MD, PhD.
Related Content